InvestorsHub Logo
Followers 43
Posts 3478
Boards Moderated 0
Alias Born 03/10/2017

Re: Flexroy post# 396988

Friday, 08/20/2021 9:17:21 AM

Friday, August 20, 2021 9:17:21 AM

Post# of 705727
Totally agree Flexroy.

Review articles are done to summarize a given field, summarizing the available developments, & outlining their comparative positive vs the negatives, BUT they are generally & for good reasons are unfamiliar with more recent advancements, eg; progress in automation to assist in maturations/expansions of cell-based therapies as NWBO has been more recently done & protecting the said IP...

In additions, the reviews generally end up taking more favorably in favor of newest approaches/technologies, but they lack any tangible data from the use of the proposed new technology to see if it actually works.

IMO, this is a very positive article for NWBO....

Very Long NWBO!!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News